State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin, China.
College of Animal Science, Zhejiang University, Hangzhou, China.
Immunol Lett. 2020 Jan;217:116-125. doi: 10.1016/j.imlet.2019.10.013. Epub 2019 Oct 25.
Mucosal immunization has potential benefits over conventional parenteral immunization, eliciting immune defense in both mucosal and systemic tissue for protecting from pathogen invasion at mucosal surfaces. To provide a first line of protection at these entry ports, mucosal vaccines have been developed and hold a significant promise for reducing the burden of infectious diseases. However, until very recently, only limited mucosal vaccines are available. This review summarizes recent advances in selected aspects regarding mucosal vaccination, including appropriate administration routes, reasonable formulations, antigen-sampling and immune responses of mucosal immunity, and the strategies used to improve mucosal vaccine efficacy. Finally, the challenges of developing successful mucosal vaccines and the potential solutions are discussed.
黏膜免疫接种相对于传统的注射免疫接种具有潜在的优势,它可以在黏膜和全身组织中引发免疫防御,以防止病原体在黏膜表面的入侵。为了在这些入口处提供第一道防线,已经开发了黏膜疫苗,并为减轻传染病负担提供了巨大的希望。然而,直到最近,只有有限的黏膜疫苗可用。本文综述了黏膜免疫接种的几个方面的最新进展,包括合适的给药途径、合理的制剂、黏膜免疫的抗原采样和免疫反应,以及提高黏膜疫苗效力的策略。最后,讨论了开发成功的黏膜疫苗所面临的挑战和潜在的解决方案。
Immunol Lett. 2019-10-25
Hum Vaccin Immunother. 2016-4-2
Expert Rev Anti Infect Ther. 2009-2
Annu Rev Biomed Eng. 2012-4-18
Recent Pat Drug Deliv Formul. 2007
Vaccine. 2011-11-12
Trends Immunol. 2002-4
J Am Chem Soc. 2025-7-23
Front Cell Infect Microbiol. 2025-5-13
Hum Vaccin Immunother. 2025-12
J Inflamm (Lond). 2025-4-14